½ÃÀ庸°í¼­
»óǰÄÚµå
1504234

¾È³» ·»Áî ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø, µ¿Ç⠺м®, À¯Çüº°, Àç·áº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ½ÃÀå ¿¹Ãø(-2031³â)

Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User - Global Forecast to 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Meticulous Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 5-7ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾È³» ·»Áî ½ÃÀåÀº 2024-2031³â°£ 6.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2031³â¿¡´Â 71¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â Á¾ÇÕÀûÀÎ 1Â÷ ¹× 2Â÷ Á¶»ç, ½ÃÀå ½Ã³ª¸®¿À¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼®À» ¹ÙÅÁÀ¸·Î ¾÷°èÀÇ ÁÖ¿ä µ¿ÀÎ, Á¦¾à, µµÀü °úÁ¦, ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡, ¹é³»Àå ¼ö¼ú °Ç¼ö Áõ°¡, µðÁöÅÐ ±â±â °ú´Ù »ç¿ëÀ¸·Î ÀÎÇÑ ½Ã°¢ Àå¾Ö, ¾È°ú ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»óÀ» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀçÁ¤ Áö¿ø µîÀÌ ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÃÖ¼Ò Ä§½ÀÀû ¾È°ú ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ¾È³» ·»ÁîÀÇ ³ôÀº ºñ¿ë°ú »óȯ Á¤Ã¥ÀÇ ºÎÀç´Â ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾È³» ·»ÁîÀÇ µå¹® ÇÕº´ÁõÀº ÀÌ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ±â¾÷µé¿¡°Ô µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • °úÁ¦
  • ±â¼ú µ¿Çâ/½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • °¡°Ý ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ¾È³» ·»Áî ½ÃÀå : À¯Çüº°

  • °³¿ä
  • ´ÜÃÊÁ¡ ·»Áî
  • ´ÙÃÊÁ¡ ·»Áî
  • ±¼Àý ±³Á¤ ·»Áî
  • Å丯 ·»Áî
  • Phakic Lenses
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ¾È³» ·»Áî ½ÃÀå : Àç·áº°

  • °³¿ä
  • ¼Ò¼ö¼º ¾ÆÅ©¸±
  • Ä£¼ö¼º ¾ÆÅ©¸±
  • Æú¸® ¸ÞŸũ¸±»ê¸ÞÆ¿(PMMA)
  • ½Ç¸®ÄÜ
  • ±âŸ Àç·á

Á¦7Àå ¼¼°èÀÇ ¾È³» ·»Áî ½ÃÀå : ¿ëµµº°

  • °³¿ä
  • ¹é³»Àå ¼ö¼ú
  • ³­½Ã ¼ö¼ú
  • °¢¸· Áúȯ
  • ±âŸ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ ¾È³» ·»Áî ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)

Á¦9Àå ¾È³» ·»Áî Áö¿ªº° ½ÃÀå

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ½ºÀ§½º
    • ¾ÆÀÏ·£µå
    • µ§¸¶Å©
    • º§±â¿¡
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ºÐ¼®

  • °³¿ä
  • ÁÖ¿ä ¼ºÀå Àü·«
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀï ´ë½Ãº¸µå
    • ½ÃÀå ¸®´õ
    • Â÷º°È­ ¿äÀÎ
    • ¼±Çà ±â¾÷
    • ½Å±Ô ±â¾÷
  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)

Á¦11Àå ±â¾÷ °³¿ä(±â¾÷ °³¿ä, À繫 °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû Àü°³)

  • Alcon, Inc.
  • Johnson & Johnson Services, Inc.
  • Carl Zeiss Meditec AG
  • Hoya Corporation
  • Beaver-Visitec International
  • Ophtec B.V.
  • Appasamy Associates Private Limited
  • Atia Vision, Inc.
  • LENSTEC, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Rayner Group
  • EyeKon Medical, Inc.
  • Humanoptics Holding AG

(ÁÖ : ÁÖ¿ä 5°³»çÀÇ SWOT ºÐ¼®À» °ÔÀç)

Á¦12Àå ºÎ·Ï

LSH 24.07.10

Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User-Global Forecast to 2031

The intraocular lens market is projected to reach $7.17 billion by 2031, at a CAGR of 6.5% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising geriatric population, increasing number of cataract surgeries, visual impairment due to excessive use of digital devices, and government initiatives and funding to improve accessibility to eye care services.

Furthermore, the rising preference for minimally invasive ophthalmic surgeries provides a significant growth opportunity for this market. However, the high costs of intraocular lenses and the unavailability of reimbursement policies may restrain its growth. Additionally, rare complications of IOL pose a challenge for the players operating in this market.

Among types, in 2024, the multifocal intraocular lenses segment is expected to account for the largest share of 28.9% of the intraocular lens market. The large share of the segment is attributed to factors such as proven/predictable results, cost-effectiveness, minimum maintenance, and the high prevalence of cataracts in older people. The key market players are undertaking various strategic initiatives to innovate multifocal intraocular lenses. For instance, in July 2022, Lenstec, Inc. (U.S.) received U.S. Food and Drug Administration (FDA) approval for the SBL-3 Multifocal Intraocular Lens (IOL), which is permanently implanted inside the eye. The SBL-3 is a multifocal intraocular lens with two zones that focus light-one from objects far away (distance vision) and the other from objects close up (near vision).

Among materials, in 2024, the hydrophobic acrylic segment is expected to account for the largest share of the intraocular lens market. Hydrophobic acrylic is the most commonly used type of material in IOLs. This material is composed of crosslinked copolymers of acrylic esters and other acrylic ester co-monomers, with a carbon backbone and ester side groups. The large share of the segment is attributed to factors such as the increasing popularity of ophthalmologists, good mechanical stability, good uveal biocompatibility, ease of manufacturing, and lower rates of complications in IOL.

Among applications, in 2024, the cataract surgery segment is expected to account for the largest share of the intraocular lens market. The large share of the segment is attributed to factors such as the increasing number of cataract surgeries, growing demand for intraocular lenses, and increasing technological advancements in intraocular lenses.

Among end users, in 2024, the hospitals products segment is expected to account for the largest share of the intraocular lens market. The large share of the market is attributed to factors such as the increasing prevalence of eye diseases and disorders and increasing awareness of ocular diseases leading to rising visits to hospitals.

An in-depth analysis of the geographical scenario of the intraocular lens market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, Asia-Pacific is slated to register the highest CAGR of 8.5% of the intraocular lens market. The high growth of the segment is primarily attributed to the rising geriatric population in countries such as China and India, the adoption of advanced healthcare resources, and rising awareness regarding the benefits of vision care products. Furthermore, the increasing affordability and availability of vision treatment providers also contribute to the growth of this market.

The key players operating in the intraocular lens market are Alcon, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Beaver-Visitec International (U.S.), Ophtec B.V. (Netherlands), Appasamy Associates Private Limited (India), Atia Vision, Inc. (U.S.), LENSTEC, Inc. (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Rayner Group (U.K.), EyeKon Medical, Inc. (U.S.), and Humanoptics Holding AG (Germany).

Scope of the Report:

Intraocular Lens Market-by Type

  • Multifocal Lenses
  • Monofocal Lenses
  • Accommodative Lenses
  • Toric Lenses
  • Phakic Lenses
  • Other Lenses

(Other lenses include extended depth-of-focus (EDOF) lenses and light adjustable lenses, among others)

Intraocular Lens Market-by Material

  • Hydrophobic Acrylic
  • Hydrophilic Acrylic
  • Polymethyl Methacrylate
  • Silicone
  • Other Materials

(Other materials include Collamer (Collagen+Polymer) and PEG-PHS/HEMA/Styrene (PHS) Copolymer, among others)

Intraocular Lens Market-by Application

  • Cataract Surgery
  • Astigmatism
  • Corneal Disorders
  • Other Applications

(Other applications include presbyopia, nearsightedness, and farsightedness)

Intraocular Lens Market-by End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgery Centers
  • Eye Research Institutes

Intraocular Lens Market-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Ireland
    • Denmark
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Rising Geriatric Population
    • 4.2.2. Increasing Number of Cataract Surgeries
    • 4.2.3. Visual Impairment Due to Excessive Use of Digital Devices
    • 4.2.4. Government Initiatives and Funding to Improve Accessibility to Eye Care Services
  • 4.3. Restraints
    • 4.3.1. High Costs of Intraocular Lenses
    • 4.3.2. Unavailability of Reimbursement Policies
  • 4.4. Opportunities
    • 4.4.1. Rising Preference for Minimally Invasive Ophthalmic Surgeries
  • 4.5. Challenges
    • 4.5.1. Rare Complications of Intraocular Lenses
  • 4.6. Technology Trends/Market Trends
    • 4.6.1. Emergence of New Technologies in Intraocular Lenses
    • 4.6.2. Use of Next-Generation Monofocal IOLs
    • 4.6.3. Growing Use of Biocompatible Materials in Lenses
  • 4.7. Regulatory Scenario
  • 4.8. Pricing Analysis
  • 4.9. Porter's Five Forces Analysis

5. Global Intraocular Lens Market-by Type

  • 5.1. Overview
  • 5.2. Monofocal Lenses
  • 5.3. Multifocal Lenses
  • 5.4. Accommodative Lenses
  • 5.5. Toric Lenses
  • 5.6. Phakic Lenses
  • 5.7. Other Types

6. Global Intraocular Lens Market-by Material

  • 6.1. Overview
  • 6.2. Hydrophobic Acrylic
  • 6.3. Hydrophilic Acrylic
  • 6.4. Polymethyl Methacrylate (PMMA)
  • 6.5. Silicone
  • 6.6. Other Materials

7. Global Intraocular Lens Market-by Application

  • 7.1. Overview
  • 7.2. Cataract Surgery
  • 7.3. Astigmatism
  • 7.4. Corneal Disorders
  • 7.5. Other Applications

8. Global Intraocular Lens Market-by End User

  • 8.1. Overview
  • 8.2. Hospitals
  • 8.3. Ophthalmic Clinics
  • 8.4. Ambulatory Surgery Centers

9. Intraocular Lens Market-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Switzerland
    • 9.3.7. Ireland
    • 9.3.8. Denmark
    • 9.3.9. Belgium
    • 9.3.10. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. South Korea
    • 9.4.5. Rest of Asia Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Market Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis (2023)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Alcon, Inc.
  • 11.2. Johnson & Johnson Services, Inc.
  • 11.3. Carl Zeiss Meditec AG
  • 11.4. Hoya Corporation
  • 11.5. Beaver-Visitec International
  • 11.6. Ophtec B.V.
  • 11.7. Appasamy Associates Private Limited
  • 11.8. Atia Vision, Inc.
  • 11.9. LENSTEC, Inc.
  • 11.10. Santen Pharmaceutical Co., Ltd.
  • 11.11. Rayner Group
  • 11.12. EyeKon Medical, Inc.
  • 11.13. Humanoptics Holding AG

(Note: SWOT analysis of the top 5 companies is provided.)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦